
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Lucius Version of Sunitinib: Dosage and Administration, Indications, PrecautionsIndicationsSunitinib is a kinase inhibitor indicated for the treatment of:Gastrointestinal stromal t···【more】
Article source:Captain MedicineRelease date:2025-12-01Recommended:130
Lucius Version of Tazemetostat: Dosage and Administration, Indications, PrecautionsIndicationsTazemetostat is a methyltransferase inhibitor indicated for the treatment of:Adult and···【more】
Article source:Captain MedicineRelease date:2025-11-28Recommended:157
Lucius Version of Futibatinib: Dosage and Administration, Indications, PrecautionsIndicationsFutibatinib is a kinase inhibitor indicated for the treatment of adult patients with pr···【more】
Article source:Captain MedicineRelease date:2025-11-28Recommended:164
Correct understanding of drug properties is of guiding significance for treatment decisions.Are the side effects of abuxitinib serious?Understanding the potential impact of treatme···【more】
Article source:Captain MedicineRelease date:2025-06-11Recommended:221
Understanding the potential impact of abuxitinib can help patients make informed decisions.What are the side effects of using abuxitinib?Familiarity with these reactions can help u···【more】
Article source:Captain MedicineRelease date:2025-06-10Recommended:225
This article examines the performance of abuxitinib in the treatment of atopic dermatitis and its economic implications.How effective is the treatment of abuxitinib?It is important···【more】
Article source:Captain MedicineRelease date:2025-06-10Recommended:235
As an oral drug targeting specific immune responses, abuxitinib has attracted attention in clinical applications in recent years.Is abuxitinib effective?Its mechanism of action pro···【more】
Article source:Captain MedicineRelease date:2025-06-09Recommended:235
As a new type of therapeutic drug, aboxitinib has attracted attention in clinical application in recent years.How effective is the treatment of abuxitinib?Its mechanism of action a···【more】
Article source:Captain MedicineRelease date:2025-06-09Recommended:201
Knowing the correct dosage of abuxitinib is critical to improving the effectiveness of treatment.What is the dosage of abuxitinibThe standard dose of abuxitinib is 100 mg once dail···【more】
Article source:Captain MedicineRelease date:2025-06-06Recommended:218
Understanding the correct way to use abuxitinib is critical to the effectiveness of treatment.How to use abuxitinibAbuxitinib is indicated for adult patients with specific skin pro···【more】
Article source:Captain MedicineRelease date:2025-06-06Recommended:214
Understanding the dosage of the drug is critical to the course of treatment.What is the recommended dosage of abuxitinib?The usual regimen of abuxitinib is oral once daily.Standard···【more】
Article source:Captain MedicineRelease date:2025-05-19Recommended:260
This article discusses the applicable population and clinical use of abuxitinib.What are the suitable populations for abuxitinib?Knowing who the drug is suitable for can help make ···【more】
Article source:Captain MedicineRelease date:2025-05-19Recommended:286
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:4502025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:6372024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended:932026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:4162025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:4372025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:4212025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:4772025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:3862025-01-12

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643